What's new in ADA Standards of Care in Diabetes?
ADA Scientific Sessions highlight updated Standards of Care guidelinesUpdates include teplizumab to delay type 1 diabetes onset and early screening for liver disease.
> Read more
News and insights brought to you by the International Diabetes Federation
Apply filters
A carefully selected mix of IDF announcements and global news stories summarised for you. Our selections are geographically based from IDF regions and thematic topics including advocacy, economics, science and technology, and more. Get informed!
1 in 3 study participants presented with renal or cardiac damages
The early burden of cardiac and renal disease in type 2 diabetesHeart failure and chronic kidney disease are the first and most frequent manifestations of cardiovascular disease in people with type 2 diabetes and are also associated with increased morbidity and mortality risks.
> Read more-
From revelations in treatment options to the likelihood of inheriting type 1 diabetes, the presentations at EASD 2024 will potentially shape the future of diabetes management and prevention. -
Studies presented at ADA showcase new treatment options for type 2 diabetes and weight management for obesity.
-
Research presented highlights the benefits of CGM metrics in predicting the progression and risk of the condition.
Do you like what you see?
Subscribe to our e-alerts.
Subscribe to our e-alerts.